{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:40:07Z","timestamp":1761100807310,"version":"build-2065373602"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":3386,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.bbmt.2005.10.002","type":"journal-article","created":{"date-parts":[[2006,1,8]],"date-time":"2006-01-08T07:08:10Z","timestamp":1136704090000},"page":"77-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"S1","title":["Using Genomics to Identify High-Risk Myeloma after Autologous Stem Cell Transplantation"],"prefix":"10.1016","volume":"12","author":[{"suffix":"Jr","given":"John D.","family":"Shaughnessy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart","family":"Barlogie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2005.10.002_bib1","series-title":"Williams Hematology","first-page":"1279","article-title":"Plasma cell myeloma","author":"Barlogie","year":"2001"},{"key":"10.1016\/j.bbmt.2005.10.002_bib2","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1056\/NEJMoa022340","article-title":"High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma","volume":"348","author":"Child","year":"2003","journal-title":"N Engl J Med."},{"key":"10.1016\/j.bbmt.2005.10.002_bib3","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1056\/NEJMoa032290","article-title":"Single versus double autologous stem-cell transplantation for MM","volume":"349","author":"Attal","year":"2003","journal-title":"N Engl J Med."},{"key":"10.1016\/j.bbmt.2005.10.002_bib4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1182\/blood-2003-04-1045","article-title":"Treatment of multiple myeloma","volume":"103","author":"Barlogie","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.10.002_bib5","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1158\/0008-5472.CAN-03-2876","article-title":"Genetics and cytogenetics of MM","volume":"64","author":"Fonseca","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbmt.2005.10.002_bib6","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/sj.leu.2401041","article-title":"Chromosomal analysis in multiple myeloma","volume":"12","author":"Smadja","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2005.10.002_bib7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrc746","article-title":"MM","volume":"2","author":"Kuehl","year":"2002","journal-title":"Nat Rev Cancer."},{"key":"10.1016\/j.bbmt.2005.10.002_bib8","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1034\/j.1600-065X.2003.00054.x","article-title":"Interpreting the molecular biology and clinical behavior of MM through global gene expression profiling","volume":"94","author":"Shaughnessy","year":"2003","journal-title":"Immunol Rev."},{"key":"10.1016\/j.bbmt.2005.10.002_bib9","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1182\/blood-2003-02-0493","article-title":"The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma","volume":"102","author":"Fonseca","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.10.002_bib10","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/gcc.10275","article-title":"Further cytogenetic characterization of multiple myeloma confirms that 14q32 translocations are a very rare event in hyperdiploid cases","volume":"38","author":"Smadja","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.bbmt.2005.10.002_bib11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0165-4608(94)00284-I","article-title":"Cytogenetic findings in 200 patients with multiple myeloma","volume":"82","author":"Sawyer","year":"1995","journal-title":"Cancer Genet Cytogenet."},{"key":"10.1016\/j.bbmt.2005.10.002_bib12","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1182\/blood-2005-01-0034","article-title":"Cyclin D dysregulation","volume":"106","author":"Bergsagel","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.10.002_bib13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/sj.leu.2403586","article-title":"Ploidy, as detected by fluorescence in situ hybridization, defines different subgroups in multiple myeloma","volume":"19","author":"Wuilleme","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2005.10.002_bib14","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/gcc.20231","article-title":"Delineation of distinct subgroups of multiple myeloma and a model for clonal evolution based on interphase cytogenetics","volume":"44","author":"Cremer","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.bbmt.2005.10.002_bib15","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1182\/blood-2002-10-3017","article-title":"Clinical and biologic implications of recurrent genomic aberrations in myeloma","volume":"101","author":"Fonseca","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.10.002_bib16","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1182\/blood-2002-12-3789","article-title":"Cyclin D1 overexpression is a favorable prognostic variable for newly diagnosed multiple myeloma patients treated with high-dose chemotherapy and single or double autologous transplantation","volume":"102","author":"Soverini","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.10.002_bib17","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1182\/blood-2002-06-1675","article-title":"In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression","volume":"101","author":"Keats","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.10.002_bib18","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1182\/blood.V98.7.2229","article-title":"Hypodiploidy is a major prognostic factor in multiple myeloma","volume":"98","author":"Smadja","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.10.002_bib19","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1046\/j.1365-2141.2002.03757.x","article-title":"Both hypodiploidy and deletion of chromosome 13 independently confer poor prognosis in multiple myeloma","volume":"118","author":"Fassas","year":"2002","journal-title":"Br J Haematol."},{"key":"10.1016\/j.bbmt.2005.10.002_bib20","first-page":"715","article-title":"Biological and prognostic significance of interphase fluorescence in situ hybridization detection of chromosome 13 abnormalities (delta13) in multiple myeloma","volume":"62","author":"Fonseca","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbmt.2005.10.002_bib21","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1182\/blood-2002-09-2873","article-title":"Continuous absence of metaphase-defined cytogenetic abnormalities, especially of chromosome 13 and hypodiploidy, ensures long-term survival in multiple myeloma treated with Total Therapy I","volume":"101","author":"Shaughnessy","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.10.002_bib22","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1182\/blood-2005-04-1411","article-title":"Clinical implications of t(11;14)(q13;q32), t(4;14)(p16.3;q32), and -17p13 in myeloma patients treated with high-dose therapy","volume":"106","author":"Gertz","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.10.002_bib23","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1056\/NEJMoa030847","article-title":"The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma","volume":"349","author":"Tian","year":"2003","journal-title":"N Engl J Med."},{"key":"10.1016\/j.bbmt.2005.10.002_bib24","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1056\/NEJM200407083510223","article-title":"Bone lesions in molecular subtypes of multiple myeloma","volume":"351","author":"Robbiani","year":"2004","journal-title":"N Engl J Med."},{"key":"10.1016\/j.bbmt.2005.10.002_bib25","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1182\/blood.V99.5.1745","article-title":"Global gene expression profiling of MM, monoclonal gammopathy of undetermined significance and normal bone marrow plasma cells","volume":"99","author":"Zhan","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.10.002_bib26","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood.V100.4.1417.h81602001417_1417_1424","article-title":"Genomic abnormalities in monoclonal gammopathy of undetermined significance","volume":"100","author":"Fonseca","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.10.002_bib27","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1038\/sj.leu.2403518","article-title":"Both IGH translocations and chromosome 13q deletions are early events in monoclonal gammopathy of undetermined significance and do not evolve during transition to multiple myeloma","volume":"18","author":"Kaufmann","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2005.10.002_bib28","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1182\/blood-2005-02-0761","article-title":"A validated FISH trisomy index demonstrates the hyperdiploid and nonhyperdiploid dichotomy in MGUS","volume":"106","author":"Chng","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.10.002_bib29","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1182\/blood.V91.5.1732","article-title":"Jumping translocations of chromosome 1q in multiple myeloma","volume":"91","author":"Sawyer","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.10.002_bib30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/gcc.20109","article-title":"Genomic instability in multiple myeloma","volume":"42","author":"Sawyer","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.bbmt.2005.10.002_bib31","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/(SICI)1098-2264(199706)19:2<124::AID-GCC8>3.0.CO;2-0","article-title":"Molecular cytogenetic abnormalities in multiple myeloma and plasma cell leukemia measured using comparative genomic hybridization","volume":"19","author":"Avet-Loiseau","year":"1997","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.bbmt.2005.10.002_bib32","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1046\/j.1365-2141.2003.04417.x","article-title":"Value of comparative genomic hybridization and fluorescence in situ hybridization for molecular diagnostics in multiple myeloma","volume":"122","author":"Liebisch","year":"2003","journal-title":"Br J Haematol."},{"key":"10.1016\/j.bbmt.2005.10.002_bib33","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1046\/j.1365-2141.2003.04221.x","article-title":"A pooled analysis of karyotypic patterns, breakpoints and imbalances in 783 cytogenetically abnormal multiple myelomas reveals frequently involved chromosome segments as well as significant age- and sex-related differences","volume":"120","author":"Nilsson","year":"2003","journal-title":"Br J Haematol."},{"key":"10.1016\/j.bbmt.2005.10.002_bib34","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1182\/blood-2004-04-1319","article-title":"Prognostic and biologic significance of chromosomal imbalances assessed by comparative genomic hybridization in MM","volume":"104","author":"Gutierrez","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.10.002_bib35","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/gcc.1189","article-title":"Novel evidence of a role for chromosome 1 pericentric heterochromatin in the pathogenesis of B-cell lymphoma and multiple myeloma","volume":"32","author":"Le Baccon","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.bbmt.2005.10.002_bib36","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/35060126","article-title":"The cell-cycle regulatory protein Cks1 is required for SCFSkp2-mediated ubiquitinylation of p27","volume":"3","author":"Ganoth","year":"2001","journal-title":"Nat Cell Biol."},{"key":"10.1016\/j.bbmt.2005.10.002_bib37","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S1097-2765(01)00210-6","article-title":"A CDK-independent function of mammalian Cks1","volume":"7","author":"Spruck","year":"2001","journal-title":"Mol Cell"},{"key":"10.1016\/j.bbmt.2005.10.002_bib38","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1101\/gad.13.12.1501","article-title":"CDK inhibitors","volume":"13","author":"Sherr","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbmt.2005.10.002_bib39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1044-579X(02)00098-6","article-title":"Deregulated degradation of the cdk inhibitor p27 and malignant transformation","volume":"13","author":"Bloom","year":"2003","journal-title":"Semin Cancer Biol."},{"key":"10.1016\/j.bbmt.2005.10.002_bib40","first-page":"820","article-title":"Low p27Kip1 expression is an independent adverse prognostic factor in patients with multiple myeloma","volume":"9","author":"Filipits","year":"2003","journal-title":"Clin Cancer Res."},{"key":"10.1016\/j.bbmt.2005.10.002_bib41","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1535-6108(03)00243-5","article-title":"When protein destruction runs amok, malignancy is on the loose","volume":"4","author":"Pagano","year":"2003","journal-title":"Cancer Cell"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879105006786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879105006786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:25:36Z","timestamp":1761056736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879105006786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S1083879105006786"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2005.10.002","relation":{},"ISSN":["1083-8791"],"issn-type":[{"type":"print","value":"1083-8791"}],"subject":[],"published":{"date-parts":[[2006,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Using Genomics to Identify High-Risk Myeloma after Autologous Stem Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2005.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}